This paper highlights the gaps in knowledge relating to the implementation of shared care cancer follow-up models in Australia. It focuses on some of the key considerations for implementing shared care, including the need to collect primary care data and link this to patient health...
This is the second in Yooralla's 'Insights into Practice' series, which provide plain language summaries of key topics in disability support. People with disability are less likely to take part in national screening programs for bowel, breast and cervical cancers. This briefing discusses steps to...
Socioeconomic status is a strong predictor of many health outcomes. However, with cancer it is a far more complicated picture.
This inquiry was initiated to respond to community concerns about the possibility of a cancer cluster or auto-immune disease cluster on the Bellarine Peninsula, and to explore any potential links between these diseases and certain chemicals that were historically used for mosquito control in the...
The National Cervical Screening Program (NCSP) is one of Australia’s three population-based cancer screening programs. This is the second report to monitor the National Cervical Screening Program since it introduced 5-yearly HPV tests in 2017.
This is the final report from the Northern Territory Government on the investigations into the findings of a retrospective cohort study on long-term Aboriginal residents living in the Gunbalanya-Kakadu area.
Review of the impact of COVID-19 on medical services and procedures in Australia utilising MBS data: lung and prostate cancers
This report provides findings from an analysis of Medicare Benefits Schedule (MBS) data for the months January 2020 to June 2020 to understand where changes in the number of cancer-related services have occurred, and the types of services affected during the COVID-19 pandemic. These analyses...
Review of the impact of COVID-19 on medical services and procedures in Australia utilising MBS data: skin, breast and colorectal cancers, and telehealth services
This report provides findings from an analysis of Medicare Benefits Schedule (MBS) for the months January 2020 to June 2020 to understand where changes in the number of cancer-related services have occurred, and the types of services affected during the COVID-19 pandemic. This analyses focuses...
This report presents statistics on the National Bowel Cancer Screening Program (NBCSP) using key performance indicators.
Cancer care in the time of COVID-19: a conceptual framework for the management of cancer during a pandemic
This conceptual framework uses published data and guidance to explore system-wide approaches to cancer management during the COVID-19 pandemic. The framework is intended as a useful resource for cancer organisations, health professionals, medical colleges and policy-makers.
The summary provides information on the extent of cancer among Aboriginal and Torres Strait Islander people, the risk factors that contribute to cancer and strategies in place to reduce its impact on individuals and communities.
Engaging with Indigenous Australian communities for a human papilloma virus and oropharyngeal cancer project; use of the CONSIDER statement
This paper outlines the engagement, consultation and recruitment strategies for a study involving investigation of HPV and OPSCC among Indigenous South Australians.
Shaping the Future: Indigenous people and cancer roundtable, 11-12 September 2018, Sydney, Australia,
The Shaping the Future: Indigenous People and Cancer 2018 Roundtable provided an opportunity to consider current issues and trends and envisage a future that best supports Aboriginal and Torres Strait Islander people affected by cancer.
This strategy document provides high level direction to guide the optimal delivery of cancer control and research to meet the needs of Western Australians impacted by cancer. The plan supports cancer control and research organisations to embrace innovation and change, be outward looking and fit...
The New Zealand Cancer Action Plan 2019-2020 provides a pathway to improve cancer outcomes for all New Zealanders. On 1 December 2019, the government launched the Cancer Control Agency to lead the implementation of this plan.
This report aims to explore the multifaceted cost of cancer and documents the impact it has upon all the lives it touches – patients, survivors, carers and family members.
This is the first report to monitor the National Cervical Screening Program since it introduced 5-yearly HPV tests in 2017. In 2018, among women aged 25–74, 1,795,395 had an HPV test, and 9% of all screening HPV tests performed were positive for HPV types that...
Most New Zealanders will be impacted by cancer in their lifetime – either directly, or through friends or family members affected by cancer. This plan sets NZ on a path to better cancer prevention, treatment and care over the next 10 years, so that New...
This report presents the latest available information on the incidence of mesothelioma in Australia, along with mortality and asbestos exposure information, using data from the Australian Mesothelioma Registry, the National Mortality Database and the Australian Cancer Database.
Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers
In this paper, experts in their fields provide perspectives on the current state of play and future directions for screening and surveillance for melanoma, Lynch syndrome, and liver, lung and prostate cancers in Australia.